Your browser is no longer supported. Please, upgrade your browser.
Settings
CERC Cerecor Inc. daily Stock Chart
CERC [NASD]
Cerecor Inc.
Index- P/E- EPS (ttm)-0.67 Insider Own0.90% Shs Outstand53.94M Perf Week20.16%
Market Cap157.56M Forward P/E- EPS next Y-0.49 Insider Trans- Shs Float51.37M Perf Month26.96%
Income-33.30M PEG- EPS next Q-0.11 Inst Own60.00% Short Float1.00% Perf Quarter-5.19%
Sales6.90M P/S22.84 EPS this Y64.30% Inst Trans34.47% Short Ratio2.27 Perf Half Y-22.55%
Book/sh0.47 P/B6.21 EPS next Y121.10% ROA- Target Price- Perf Year-38.14%
Cash/sh0.38 P/C7.72 EPS next 5Y- ROE- 52W Range1.52 - 6.19 Perf YTD-45.83%
Dividend- P/FCF- EPS past 5Y1.40% ROI-78.20% 52W High-52.83% Beta1.81
Dividend %- Quick Ratio1.70 Sales past 5Y- Gross Margin- 52W Low92.11% ATR0.30
Employees18 Current Ratio1.70 Sales Q/Q7.70% Oper. Margin- RSI (14)62.88 Volatility22.40% 11.17%
OptionableYes Debt/Eq0.00 EPS Q/Q-228.50% Profit Margin- Rel Volume1.02 Prev Close2.96
ShortableYes LT Debt/Eq0.00 EarningsMay 07 AMC Payout- Avg Volume225.97K Price2.92
Recom1.70 SMA2020.10% SMA5017.25% SMA200-13.39% Volume228,768 Change-1.35%
Mar-13-20Downgrade Maxim Group Buy → Hold
Jan-10-20Initiated Oppenheimer Outperform
Apr-09-19Initiated Maxim Group Buy $10
Apr-01-19Initiated H.C. Wainwright Buy $11
Dec-20-18Initiated Ladenburg Thalmann Buy
Dec-12-16Downgrade Rodman & Renshaw Buy → Neutral $4 → $1
Apr-13-16Initiated Rodman & Renshaw Buy $15
Dec-09-15Initiated Laidlaw Buy $10
May-29-20 07:00AM  
May-28-20 07:00AM  
May-26-20 07:00AM  
May-13-20 06:00AM  
May-07-20 06:30AM  
May-04-20 09:15AM  
Apr-24-20 01:45PM  
Mar-27-20 09:39PM  
Mar-26-20 06:30AM  
Mar-19-20 08:50AM  
Mar-13-20 07:18AM  
06:59AM  
Mar-11-20 06:30AM  
Mar-06-20 09:00AM  
Feb-04-20 01:31PM  
Feb-03-20 04:15PM  
Dec-23-19 10:26AM  
Dec-13-19 09:50AM  
Dec-10-19 03:20PM  
Dec-05-19 08:45AM  
Nov-14-19 06:30AM  
Nov-11-19 06:30AM  
Nov-04-19 06:30AM  
Oct-23-19 11:27AM  
Oct-14-19 06:30AM  
Aug-21-19 07:42AM  
06:30AM  
Aug-08-19 04:05PM  
Jul-29-19 06:30AM  
Jul-25-19 03:22PM  
Jul-23-19 10:00AM  
Jul-15-19 06:30AM  
Jul-02-19 12:03PM  
Jul-01-19 06:30AM  
Jun-28-19 02:19PM  
06:30AM  
Jun-12-19 04:05PM  
Jun-11-19 01:00PM  
May-13-19 02:00PM  
May-09-19 04:05PM  
Apr-29-19 10:38AM  
06:30AM  
Apr-17-19 10:15AM  
Apr-15-19 06:30AM  
Apr-11-19 06:30AM  
Mar-26-19 10:30AM  
Mar-18-19 04:05PM  
Mar-06-19 06:05AM  
Mar-05-19 05:30PM  
Feb-22-19 10:11AM  
Feb-19-19 08:27AM  
Feb-15-19 06:30AM  
Jan-28-19 06:30AM  
Jan-22-19 06:30AM  
Jan-16-19 06:30AM  
Dec-13-18 07:00AM  
Nov-26-18 12:00PM  
Nov-22-18 02:13PM  
Nov-21-18 08:55AM  
Nov-13-18 07:00AM  
Oct-31-18 04:00PM  
Oct-30-18 04:00PM  
Oct-02-18 09:20AM  
Sep-26-18 01:00PM  
11:29AM  
Sep-25-18 06:30AM  
Aug-31-18 02:46PM  
07:00AM  
Aug-15-18 01:15PM  
Aug-09-18 06:30AM  
Aug-01-18 06:30AM  
Jul-31-18 01:37PM  
Jul-16-18 06:00AM  
Jul-12-18 02:00AM  
May-22-18 08:29AM  
May-19-18 10:02AM  
May-17-18 09:55AM  
08:01AM  
May-11-18 08:15AM  
May-10-18 07:40AM  
Apr-09-18 08:00AM  
Apr-02-18 08:00AM  
Mar-28-18 10:02AM  
08:00AM  
Mar-07-18 03:15PM  
Feb-12-18 05:06PM  
09:07AM  
Jan-10-18 07:52PM  
Dec-26-17 09:00AM  
Dec-25-17 05:45PM  
Dec-18-17 09:05AM  
Dec-08-17 10:33AM  
Nov-29-17 07:30AM  
Nov-21-17 07:40AM  
Nov-20-17 12:45PM  
Nov-17-17 10:35AM  
08:30AM  
08:15AM  
08:02AM  
Nov-09-17 11:45AM  
Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-406 for the treatment of Parkinson's disease; CERC-425, an orally active small molecule; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and CERC-913, a protide nucleotide for the treatment of mitochondrial disorder. It also developing preclinical therapies CERC-801, CERC-802, and CERC-803 for the treatment of inherited metabolic disorders. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cerecor Inc.10% OwnerApr 15Sale1.5592,777144,0929,713,068Apr 27 09:30 AM
ARMISTICE CAPITAL, LLCDirectorApr 03Buy2.164,2809,245832,194Apr 07 04:59 PM
ARMISTICE CAPITAL, LLCDirectorMar 31Buy2.3326,61162,004827,914Mar 31 05:58 PM
ARMISTICE CAPITAL, LLCDirectorMar 30Buy2.3549,303115,862801,303Mar 31 05:58 PM
ARMISTICE CAPITAL, LLCDirectorMar 27Buy2.4336,00087,480752,000Mar 31 05:58 PM
ARMISTICE CAPITAL, LLCDirectorMar 23Buy2.521,3743,462716,000Mar 24 04:47 PM
ARMISTICE CAPITAL, LLCDirectorMar 20Buy2.509,62624,065714,626Mar 24 04:47 PM
ARMISTICE CAPITAL, LLCDirectorMar 19Buy2.601,5674,074705,000Mar 19 06:39 PM
ARMISTICE CAPITAL, LLCDirectorMar 18Buy1.9128,43354,307703,433Mar 19 06:39 PM
ARMISTICE CAPITAL, LLCDirectorMar 17Buy2.051,951,2193,999,99928,160,605Mar 19 06:39 PM
ARMISTICE CAPITAL, LLCDirectorFeb 03Buy3.98275,0001,094,500675,000Feb 05 05:43 PM
ARMISTICE CAPITAL, LLCDirectorFeb 03Buy3.98981,2823,905,50229,664,515Feb 05 05:43 PM
Calias PericlesChief Scientific OfficerDec 10Buy2.852,9138,29552,462Dec 11 04:15 PM
Miller Joseph MChief Financial OfficerDec 10Buy2.852,5987,39848,777Dec 11 04:41 PM
Harrell James Archie JrChief Commercial OfficerDec 10Buy2.853,0648,72511,618Dec 11 04:28 PM
ARMISTICE CAPITAL, LLCDirectorSep 06Buy2.951,000,0002,950,00020,683,233Sep 06 07:13 PM
ARMISTICE CAPITAL, LLCDirectorSep 04Buy3.131,200,0003,756,00019,683,233Sep 06 07:13 PM
ARMISTICE CAPITAL, LLCDirectorAug 30Buy3.2324,59179,42918,483,233Sep 03 05:50 PM
ARMISTICE CAPITAL, LLCDirectorAug 29Buy3.2117,17355,12518,458,642Sep 03 05:50 PM
Pedder SimonExecutive Chairman of the BdAug 27Buy2.986,73420,100262,734Aug 29 05:03 PM
ARMISTICE CAPITAL, LLCDirectorAug 19Buy3.602,2988,28018,441,469Aug 20 07:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 16Buy3.439,88633,90918,439,171Aug 20 07:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 14Buy3.3756,842191,558400,000Aug 14 07:29 PM
ARMISTICE CAPITAL, LLCDirectorAug 13Buy3.3029,18896,320343,158Aug 14 07:29 PM
ARMISTICE CAPITAL, LLCDirectorAug 12Buy3.2013,97044,704313,970Aug 14 07:29 PM
Calias PericlesChief Scientific OfficerJun 10Buy2.854,54912,95349,549Jun 11 07:36 PM
Phillips Matthew VChief Commercial OfficerJun 10Buy2.855231,4891,020Jun 11 09:04 PM
Miller Joseph MChief Financial OfficerJun 10Buy2.851,1793,35746,179Jun 11 08:47 PM
Harrell James Archie JrExec. VP, Mktg & External CommJun 10Buy2.854,39812,5238,554Jun 11 07:51 PM
ARMISTICE CAPITAL, LLCDirectorJun 07Buy4.8810,00048,750300,000Jun 11 06:01 PM
ARMISTICE CAPITAL, LLCDirectorJun 05Buy4.975,00024,85018,429,285Jun 05 05:52 PM